跳到正文
openFDA 已分级药品召回执法报告·· 19 天前精选AI 评分64

FDA 执法报告 D-0111-2027:Brandywine 茶碱缓释片 200 mg 因第三方实验室稳定性试验中断被列为 II 类召回

FDA drug enforcement D-0111-2027: Brandywine Pharmaceuticals, LLC — CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory

AI 导读

openFDA 执法报告 D-0111-2027 显示,Brandywine Pharmaceuticals 的茶碱缓释片 200 mg(批号 405620,有效期 2028 年 3 月 31 日)因第三方实验室稳定性试验中断的 CGMP 偏差,被列为 II 类自愿召回。

推荐理由

记录显示该企业自愿召回的分类结果为 II 类,原因指向第三方实验室稳定性试验中断,可据此核对批次与分销范围。

正文 · 原文

FDA drug recall enforcement report — D-0111-2027

Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "600 W Strasburg Rd",

"address_2": "",

"center_classification_date": "20261029",

"city": "West Chester",

"classification": "Class II",

"code_info": "Lot: 405620, Expiry: 03/31/2028.",

"country": "United States",

"distribution_pattern": "Nationwide within U.S",

"event_id": "100038",

"initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",

"more_code_info": "",

"openfda": {},

"postal_code": "19382-1955",

"product_description": "Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.",

"product_quantity": "1,332 100-count bottles",

"product_type": "Drugs",

"reason_for_recall": "CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory",

"recall_initiation_date": "20261006",

"recall_number": "D-0111-2027",

"recalling_firm": "Brandywine Pharmaceuticals, LLC",

"report_date": "20261104",

"state": "PA",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov